Ondansetron: Wafer 4 mg, 8 mg; Tablet (as hydrochloride dehydrate) 4 mg, 8 mg; Tablet (orally disintegrating) 4 mg, 8 mg; various brands Page last updated: 3 July 2020 Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB) Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)